Adults dominate the ADHD prescription category; the FDA approved The Medicine Company’s anticlotting drug 10 years after issuing a CRL; a survey shows personalized content can build consumer goodwill
Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year
Study shows pharma compensates genders differently
Novo Nordisk replaces Sanofi as the top marketer of metabolic drugs; Actavis changed its name to Allergan; access to Medicare Part D has not reduced overall Medicare costs
Amgen’s PCSK9 inhibitor is the second in its class to get an FDA panel endorsement; a new drug could threaten Shire’s hold on a rare-disease category; a study shows pharma invests less in Hispanic audiences than in other groups